Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Cook, Rachel J  [Clear All Filters]
2024
Maziarz RT, Cook RJ. The rationale behind grafting haploidentical hematopoietic stem cells. Hematology. 2024;29(1):2347673.
2023
Booth G, Yu Y, Harlan RP, Jacoby CE, Tomic KM, Slater SE, Allen BE, Berklich EM, Knight RJ, Cruz JDela, et al. Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates. Cytotherapy. 2023.
2022
Rosenberg MW, Savage SL, Eide CA, Schultz AReister, Cook RJ, Press RD, Rempfer C, Eickelberg G, Wilmot B, McWeeney SK, et al. Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia. Cold Spring Harb Mol Case Stud. 2022;8(6).
2021
Newell LF, Williams T, Liu J, Yu Y, Chen Y, Booth GC, Knight RJ, Goslee KR, Cook RJ, Leonard J, et al. Engrafted donor-derived clonal hematopoiesis after allogenic hematopoietic cell transplantation is associated with chronic GVHD requiring immunosuppressive therapy, but no adverse impact on OS or relapse. Transplant Cell Ther. 2021.
2019
Lachowiez C, Cook RJ, Hayes-Lattin B, Maziarz RT, Borate U, Traer E, Leonard J, Newell L, Dao K-H, Meyers G. Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years. Hematol Oncol Stem Cell Ther. 2019.